Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin.
Turturro, Sanja B
Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin. [electronic resource] - Breast cancer research and treatment Feb 2016 - 33-43 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1573-7217
10.1007/s10549-016-3729-8 doi
Aspirin--pharmacology
Breast Neoplasms--genetics
Cell Proliferation--drug effects
Class I Phosphatidylinositol 3-Kinases
Cytostatic Agents--pharmacology
Female
Glycogen Synthase Kinase 3 beta--metabolism
Humans
MCF-7 Cells
Mutation
Phosphatidylinositol 3-Kinases--genetics
Phosphorylation
Proto-Oncogene Proteins p21(ras)--genetics
Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin. [electronic resource] - Breast cancer research and treatment Feb 2016 - 33-43 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1573-7217
10.1007/s10549-016-3729-8 doi
Aspirin--pharmacology
Breast Neoplasms--genetics
Cell Proliferation--drug effects
Class I Phosphatidylinositol 3-Kinases
Cytostatic Agents--pharmacology
Female
Glycogen Synthase Kinase 3 beta--metabolism
Humans
MCF-7 Cells
Mutation
Phosphatidylinositol 3-Kinases--genetics
Phosphorylation
Proto-Oncogene Proteins p21(ras)--genetics